{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:57:31Z","timestamp":1784894251221,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871722"],"award-info":[{"award-number":["81871722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072373"],"award-info":[{"award-number":["82072373"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002235"],"award-info":[{"award-number":["82002235"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recent studies have suggested that folic acid can restore abnormal DNA methylation and monocyte subset shifts caused by hyperhomocysteinemia (HHcy) and hyperlipidemia (HL). However, the exact mechanism of action is still not fully understood. In this study, we further investigated the reversal effect and underlying mechanism of folic acid on the shift in monocyte subsets induced by aberrant lipids and Hcy metabolism via DNA methylation in vitro and in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our results showed that intermediate monocytes were significantly increased but had the lowest global 5-methylcytosine (5-mC) levels in coronary artery disease (CAD) patients, which might lead to a decrease in the global 5-mC levels of peripheral blood leukocytes (PBLs). We also discovered that ARID5B might mediate the increased proportion of intermediate monocytes, as this factor was related to the proportion of monocyte subsets and the expression of CCR2. The expression of ARID5B was inversely associated with the hypermethylated cg25953130 CpG site, which was induced by HL and HHcy. ARID5B could also regulate monocyte CCR2, MCP-1, and TNF-\u03b1 expression, adhesion and migration, macrophage polarization, and monocyte\/macrophage apoptosis, which might explain the regulatory effect of ARID5B on monocyte subset shifting. Folic acid reversed HL- and HHcy-mediated\u00a0aberrant global and cg25953130 DNA methylation, reduced the proportion of intermediate monocytes, and inhibited the formation of atherosclerotic plaques.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Folic acid plays a protective role against atherosclerosis through the regulation of DNA methylation, ARID5B expression, and monocyte subsets.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13148-022-01248-0","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T15:13:09Z","timestamp":1646061189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Atheroprotective mechanism by which folic acid regulates monocyte subsets and function through DNA methylation"],"prefix":"10.1186","volume":"14","author":[{"given":"Yang","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2024-2424","authenticated-orcid":false,"given":"Fang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"issue":"4","key":"1248_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","volume":"16","author":"D Zhao","year":"2019","unstructured":"Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203\u201312.","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"1248_CR2","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jacc.2019.07.043","volume":"74","author":"B Rizzacasa","year":"2019","unstructured":"Rizzacasa B, Amati F, Romeo F, Novelli G, Mehta JL. Epigenetic modification in coronary atherosclerosis: JACC review topic of the week. J Am Coll Cardiol. 2019;74(10):1352\u201365.","journal-title":"J Am Coll Cardiol"},{"key":"1248_CR3","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3389\/fimmu.2019.02035","volume":"10","author":"TS Kapellos","year":"2019","unstructured":"Kapellos TS, Bonaguro L, Gem\u00fcnd I, Reusch N, Saglam A, Hinkley ER, Schultze JL. Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front Immunol. 2019;10:2035.","journal-title":"Front Immunol"},{"issue":"12","key":"1248_CR4","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1042\/CS20170009","volume":"131","author":"CN Fran\u00e7a","year":"2017","unstructured":"Fran\u00e7a CN, Izar MCO, Hort\u00eancio MNS. do Amaral JB, Ferreira CES, Tuleta ID, Fonseca FAH: Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease. Clinical Science (London, England: 1979). 2017;131(12):1215\u201324.","journal-title":"Clinical Science (London, England: 1979)"},{"key":"1248_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2017.09.032","volume":"266","author":"R Cappellari","year":"2017","unstructured":"Cappellari R, D\u2019Anna M, Bonora BM, Rigato M, Cignarella A, Avogaro A, Fadini GP. Shift of monocyte subsets along their continuum predicts cardiovascular outcomes. Atherosclerosis. 2017;266:95\u2013102.","journal-title":"Atherosclerosis"},{"issue":"16","key":"1248_CR6","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","volume":"116","author":"L Ziegler-Heitbrock","year":"2010","unstructured":"Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116(16):e74-80.","journal-title":"Blood"},{"issue":"8","key":"1248_CR7","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1161\/ATVBAHA.117.309145","volume":"37","author":"GD Thomas","year":"2017","unstructured":"Thomas GD, Hamers AAJ, Nakao C, Marcovecchio P, Taylor AM, McSkimming C, Nguyen AT, McNamara CA, Hedrick CC. Human blood monocyte subsets: a new gating strategy defined using cell surface markers identified by mass cytometry. Arterioscler Thromb Vasc Biol. 2017;37(8):1548\u201358.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1248_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2017.05.026","volume":"263","author":"VK Patel","year":"2017","unstructured":"Patel VK, Williams H, Li SCH, Fletcher JP, Medbury HJ. Monocyte inflammatory profile is specific for individuals and associated with altered blood lipid levels. Atherosclerosis. 2017;263:15\u201323.","journal-title":"Atherosclerosis"},{"issue":"8","key":"1248_CR9","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10554-017-1097-z","volume":"33","author":"SC Lo","year":"2017","unstructured":"Lo SC, Lee WJ, Chen CY, Lee BC. Intermediate CD14(++)CD16(+) monocyte predicts severe coronary stenosis and extensive plaque involvement in asymptomatic individuals. Int J Cardiovasc Imaging. 2017;33(8):1223\u201336.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"16","key":"1248_CR10","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jacc.2012.07.019","volume":"60","author":"KS Rogacev","year":"2012","unstructured":"Rogacev KS, Cremers B, Zawada AM, Seiler S, Binder N, Ege P, Gro\u00dfe-Dunker G, Heisel I, Hornof F, Jeken J, et al. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol. 2012;60(16):1512\u201320.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1248_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/eurheartj\/ehq371","volume":"32","author":"KS Rogacev","year":"2011","unstructured":"Rogacev KS, Seiler S, Zawada AM, Reichart B, Herath E, Roth D, Ulrich C, Fliser D, Heine GH. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J. 2011;32(1):84\u201392.","journal-title":"Eur Heart J"},{"issue":"2","key":"1248_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.atherosclerosis.2014.10.015","volume":"237","author":"KA Krychtiuk","year":"2014","unstructured":"Krychtiuk KA, Kastl SP, Pfaffenberger S, Pongratz T, Hofbauer SL, Wonnerth A, Katsaros KM, Goliasch G, Gaspar L, Huber K, et al. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease. Atherosclerosis. 2014;237(2):589\u201396.","journal-title":"Atherosclerosis"},{"issue":"4","key":"1248_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/15592294.2016.1158363","volume":"11","author":"AM Zawada","year":"2016","unstructured":"Zawada AM, Schneider JS, Michel AI, Rogacev KS, Hummel B, Krezdorn N, M\u00fcller S, Rotter B, Winter P, Obeid R, et al. DNA methylation profiling reveals differences in the 3 human monocyte subsets and identifies uremia to induce DNA methylation changes during differentiation. Epigenetics. 2016;11(4):259\u201372.","journal-title":"Epigenetics"},{"issue":"1","key":"1248_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/CIRCRESAHA.112.269472","volume":"111","author":"D Zhang","year":"2012","unstructured":"Zhang D, Fang P, Jiang X, Nelson J, Moore JK, Kruger WD, Berretta RM, Houser SR, Yang X, Wang H. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr\/CBS-deficient mice. Circ Res. 2012;111(1):37\u201349.","journal-title":"Circ Res"},{"issue":"11","key":"1248_CR15","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1161\/CIRCRESAHA.116.308750","volume":"119","author":"J Yang","year":"2016","unstructured":"Yang J, Fang P, Yu D, Zhang L, Zhang D, Jiang X, Yang WY, Bottiglieri T, Kunapuli SP, Yu J, et al. Chronic kidney disease induces inflammatory CD40+ monocyte differentiation via homocysteine elevation and DNA hypomethylation. Circ Res. 2016;119(11):1226\u201341.","journal-title":"Circ Res"},{"key":"1248_CR16","doi-asserted-by":"publisher","first-page":"1312626","DOI":"10.1155\/2018\/1312626","volume":"2018","author":"M Samblas","year":"2018","unstructured":"Samblas M, Mart\u00ednez JA, Milagro F. Folic acid improves the inflammatory response in LPS-activated THP-1 macrophages. Mediators Inflamm. 2018;2018:1312626.","journal-title":"Mediators Inflamm"},{"key":"1248_CR17","doi-asserted-by":"crossref","unstructured":"Fisslthaler B, Zippel N, Abdel Malik R, Delgado Lagos F, Zukunft S, Thoele J, Siuda D, Soehnlein O, Wittig I, Heidler J et al. Myeloid-specific deletion of the ampk\u03b12 subunit alters monocyte protein expression and atherogenesis. Int J Mol Sci. 2019;20(12).","DOI":"10.3390\/ijms20123005"},{"issue":"8","key":"1248_CR18","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.4049\/jimmunol.1402655","volume":"194","author":"EF Dev\u00eavre","year":"2015","unstructured":"Dev\u00eavre EF, Renovato-Martins M, Cl\u00e9ment K, Saut\u00e8s-Fridman C, Cremer I, Poitou C. Profiling of the three circulating monocyte subpopulations in human obesity. J Immunol (Baltimore, Md: 1950). 2015;194(8):3917\u201323.","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"issue":"14","key":"1248_CR19","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.7150\/ijms.47998","volume":"17","author":"Y Xiang","year":"2020","unstructured":"Xiang Y, Liang B, Zhang X, Zheng F. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis. Int J Med Sci. 2020;17(14):2171\u20139.","journal-title":"Int J Med Sci"},{"issue":"1","key":"1248_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41467-017-00517-4","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Reynolds LM, Ding J, Hou L, Lohman K, Young T, Cui W, Huang Z, Grenier C, Wan M, et al. Blood monocyte transcriptome and epigenome analyses reveal loci associated with human atherosclerosis. Nat Commun. 2017;8(1):393.","journal-title":"Nat Commun"},{"issue":"3","key":"1248_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/biof.1154","volume":"40","author":"RP da Silva","year":"2014","unstructured":"da Silva RP, Kelly KB, Al Rajabi A, Jacobs RL. Novel insights on interactions between folate and lipid metabolism. BioFactors. 2014;40(3):277\u201383.","journal-title":"BioFactors"},{"key":"1248_CR22","doi-asserted-by":"publisher","first-page":"1670815","DOI":"10.1155\/2017\/1670815","volume":"2017","author":"G Liu","year":"2017","unstructured":"Liu G, Bin P, Wang T, Ren W, Zhong J, Liang J, Hu CA, Zeng Z, Yin Y. DNA methylation and the potential role of methyl-containing nutrients in cardiovascular diseases. Oxid Med Cell Longev. 2017;2017:1670815.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"1248_CR23","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/ajcn\/nqz181","volume":"110","author":"R Fujii","year":"2019","unstructured":"Fujii R, Yamada H, Munetsuna E, Yamazaki M, Ando Y, Mizuno G, Tsuboi Y, Ohashi K, Ishikawa H, Hagiwara C, et al. Associations between dietary vitamin intake, ABCA1 gene promoter DNA methylation, and lipid profiles in a Japanese population. Am J Clin Nutr. 2019;110(5):1213\u20139.","journal-title":"Am J Clin Nutr"},{"key":"1248_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13148-018-0443-x","volume":"10","author":"Q Deng","year":"2018","unstructured":"Deng Q, Huang W, Peng C, Gao J, Li Z, Qiu X, Yang N, Yuan B, Zheng F. Genomic 5-mC contents in peripheral blood leukocytes were independent protective factors for coronary artery disease with a specific profile in different leukocyte subtypes. Clin Epigenetics. 2018;10:9.","journal-title":"Clin Epigenetics"},{"issue":"10","key":"1248_CR25","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1161\/CIRCRESAHA.117.311606","volume":"121","author":"Q Li","year":"2017","unstructured":"Li Q, Park K, Xia Y, Matsumoto M, Qi W, Fu J, Yokomizo H, Khamaisi M, Wang X, Rask-Madsen C, et al. Regulation of macrophage apoptosis and atherosclerosis by lipid-induced PKC\u03b4 isoform activation. Circ Res. 2017;121(10):1153\u201367.","journal-title":"Circ Res"},{"issue":"12","key":"1248_CR26","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1182\/blood-2011-01-326827","volume":"118","author":"AM Zawada","year":"2011","unstructured":"Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, Fliser D, Heine GH. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood. 2011;118(12):e50-61.","journal-title":"Blood"},{"issue":"7","key":"1248_CR27","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1084\/jem.20170355","volume":"214","author":"AA Patel","year":"2017","unstructured":"Patel AA, Zhang Y, Fullerton JN, Boelen L, Rongvaux A, Maini AA, Bigley V, Flavell RA, Gilroy DW, Asquith B, et al. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J Exp Med. 2017;214(7):1913\u201323.","journal-title":"J Exp Med"},{"issue":"1","key":"1248_CR28","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1038\/s41467-018-07801-x","volume":"9","author":"D Selimoglu-Buet","year":"2018","unstructured":"Selimoglu-Buet D, Rivi\u00e8re J, Ghamlouch H, Bencheikh L, Lacout C, Morabito M, Diop M, Meurice G, Breckler M, Chauveau A, et al. A miR-150\/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset. Nat Commun. 2018;9(1):5455.","journal-title":"Nat Commun"},{"issue":"2","key":"1248_CR29","first-page":"419","volume":"92","author":"A Schlitt","year":"2004","unstructured":"Schlitt A, Heine GH, Blankenberg S, Espinola-Klein C, Dopheide JF, Bickel C, Lackner KJ, Iz M, Meyer J, Darius H, et al. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost. 2004;92(2):419\u201324.","journal-title":"Thromb Haemost"},{"issue":"2","key":"1248_CR30","first-page":"131","volume":"107","author":"HP Zuo","year":"2016","unstructured":"Zuo HP, Guo YY, Che L, Wu XZ. Hypomethylation of interleukin-6 promoter is associated with the risk of coronary heart disease. Arq Bras Cardiol. 2016;107(2):131\u20136.","journal-title":"Arq Bras Cardiol"},{"issue":"4","key":"1248_CR31","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1096\/fj.201700453RR","volume":"32","author":"J Murray","year":"2018","unstructured":"Murray J, Whitson RH, Itakura K. Reduced prostaglandin I(2) signaling in Arid5b(-\/-) primary skeletal muscle cells attenuates myogenesis. FASEB J. 2018;32(4):1868\u201379.","journal-title":"FASEB J"},{"issue":"5","key":"1248_CR32","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1161\/01.RES.0000033593.05545.7B","volume":"91","author":"M Watanabe","year":"2002","unstructured":"Watanabe M, Layne MD, Hsieh CM, Maemura K, Gray S, Lee ME, Jain MK. Regulation of smooth muscle cell differentiation by AT-rich interaction domain transcription factors Mrf2alpha and Mrf2beta. Circ Res. 2002;91(5):382\u20139.","journal-title":"Circ Res"},{"key":"1248_CR33","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1038\/ncomms3850","volume":"4","author":"K Hata","year":"2013","unstructured":"Hata K, Takashima R, Amano K, Ono K, Nakanishi M, Yoshida M, Wakabayashi M, Matsuda A, Maeda Y, Suzuki Y, et al. Arid5b facilitates chondrogenesis by recruiting the histone demethylase Phf2 to Sox9-regulated genes. Nat Commun. 2013;4:2850.","journal-title":"Nat Commun"},{"issue":"1","key":"1248_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/MOH.0000000000000389","volume":"25","author":"V Bianconi","year":"2018","unstructured":"Bianconi V, Sahebkar A, Atkin SL, Pirro M. The regulation and importance of monocyte chemoattractant protein-1. Curr Opin Hematol. 2018;25(1):44\u201351.","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"1248_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cmet.2018.05.002","volume":"28","author":"C Winter","year":"2018","unstructured":"Winter C, Silvestre-Roig C, Ortega-Gomez A, Lemnitzer P, Poelman H, Schumski A, Winter J, Drechsler M, de Jong R, Immler R, et al. Chrono-pharmacological targeting of the CCL2-CCR2 axis ameliorates atherosclerosis. Cell Metab. 2018;28(1):175-182.e175.","journal-title":"Cell Metab"},{"issue":"11","key":"1248_CR36","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1182\/blood-2005-07-2872","volume":"107","author":"JW Mitchell","year":"2006","unstructured":"Mitchell JW, Baik N, Castellino FJ, Miles LA. Plasminogen inhibits TNFalpha-induced apoptosis in monocytes. Blood. 2006;107(11):4383\u201390.","journal-title":"Blood"},{"issue":"11","key":"1248_CR37","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1038\/cddis.2010.69","volume":"1","author":"C Zhao","year":"2010","unstructured":"Zhao C, Tan YC, Wong WC, Sem X, Zhang H, Han H, Ong SM, Wong KL, Yeap WH, Sze SK, et al. The CD14(+\/low)CD16(+) monocyte subset is more susceptible to spontaneous and oxidant-induced apoptosis than the CD14(+)CD16(-) subset. Cell Death Dis. 2010;1(11):e95.","journal-title":"Cell Death Dis"},{"issue":"4","key":"1248_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.tips.2015.02.005","volume":"36","author":"C Schiano","year":"2015","unstructured":"Schiano C, Vietri MT, Grimaldi V, Picascia A, De Pascale MR, Napoli C. Epigenetic-related therapeutic challenges in cardiovascular disease. Trends Pharmacol Sci. 2015;36(4):226\u201335.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"1248_CR39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/mnfr.201200636","volume":"58","author":"MB Glier","year":"2014","unstructured":"Glier MB, Green TJ, Devlin AM. Methyl nutrients, DNA methylation, and cardiovascular disease. Mol Nutr Food Res. 2014;58(1):172\u201382.","journal-title":"Mol Nutr Food Res"},{"issue":"8","key":"1248_CR40","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/bph.13988","volume":"175","author":"Y Fu","year":"2018","unstructured":"Fu Y, Wang X, Kong W. Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets. Br J Pharmacol. 2018;175(8):1173\u201389.","journal-title":"Br J Pharmacol"},{"key":"1248_CR41","doi-asserted-by":"crossref","unstructured":"Cui S, Li W, Lv X, Wang P, Gao Y, Huang G. Folic acid supplementation delays atherosclerotic lesion development by modulating MCP1 and VEGF DNA methylation levels in vivo and in vitro. Int J Mol Sci. 2017;18(5).","DOI":"10.3390\/ijms18050990"},{"issue":"4","key":"1248_CR42","first-page":"327","volume":"11","author":"A Vijayakumar","year":"2017","unstructured":"Vijayakumar A, Kim EK, Kim H, Choi YJ, Huh KB, Chang N. Effects of folic acid supplementation on serum homocysteine levels, lipid profiles, and vascular parameters in post-menopausal Korean women with type 2 diabetes mellitus. Nurs Res Pract. 2017;11(4):327\u201333.","journal-title":"Nurs Res Pract"},{"key":"1248_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.redox.2018.08.005","volume":"19","author":"S Cui","year":"2018","unstructured":"Cui S, Lv X, Li W, Li Z, Liu H, Gao Y, Huang G. Folic acid modulates VPO1 DNA methylation levels and alleviates oxidative stress-induced apoptosis in vivo and in vitro. Redox Biol. 2018;19:81\u201391.","journal-title":"Redox Biol"},{"issue":"5","key":"1248_CR44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/ng.3258","volume":"47","author":"J Liao","year":"2015","unstructured":"Liao J, Karnik R, Gu H, Ziller MJ, Clement K, Tsankov AM, Akopian V, Gifford CA, Donaghey J, Galonska C, et al. Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells. Nat Genet. 2015;47(5):469\u201378.","journal-title":"Nat Genet"},{"key":"1248_CR45","doi-asserted-by":"publisher","first-page":"101444","DOI":"10.1016\/j.redox.2020.101444","volume":"32","author":"Y Liu","year":"2020","unstructured":"Liu Y, Tian X, Liu S, Liu D, Li Y, Liu M, Zhang X, Yan C, Han Y. DNA hypermethylation: A novel mechanism of CREG gene suppression and atherosclerogenic endothelial dysfunction. Redox Biol. 2020;32:101444.","journal-title":"Redox Biol"},{"issue":"12","key":"1248_CR46","doi-asserted-by":"publisher","first-page":"741","DOI":"10.21037\/atm-19-4728","volume":"8","author":"B Liang","year":"2020","unstructured":"Liang B, Li M, Deng Q, Wang C, Rong J, He S, Xiang Y, Zheng F. CircRNA ZNF609 in peripheral blood leukocytes acts as a protective factor and a potential biomarker for coronary artery disease. Ann Transl Med. 2020;8(12):741.","journal-title":"Ann Transl Med"},{"issue":"9","key":"1248_CR47","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1161\/ATVBAHA.114.304172","volume":"34","author":"KS Rogacev","year":"2014","unstructured":"Rogacev KS, Zawada AM, Emrich I, Seiler S, B\u00f6hm M, Fliser D, Woollard KJ, Heine GH. Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease. Arterioscler Thromb Vasc Biol. 2014;34(9):2120\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-022-01248-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-022-01248-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-022-01248-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T13:02:59Z","timestamp":1666702979000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-022-01248-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1248"],"URL":"https:\/\/doi.org\/10.1186\/s13148-022-01248-0","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"assertion":[{"value":"26 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Zhongnan Hospital of Wuhan University (Approval Number, 2018017), and informed consent was obtained from all participants prior to entering the study. The animal experiments were approved by the Institutional Animal Care and Use Committee of Wuhan University (IACUC Approval Number, 2019174).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Publishing consent was obtained from all participants prior to entering the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}